Comprehensive Comparison of Somatic, Germline, and Immune Cell Profiles in Upper Tract and Bladder Urothelial Carcinoma

By comprehensive molecular characterization of UC, we observed distinct genomic alterations and tumor microenvironment patterns in UTUC and UCB. Further research is warranted to elucidate the clinical implications of these findings. We compared the genetic and immune features of upper tract and bladder cancers. Our study found key differences that could affect treatment decisions, such as specific gene changes and immune markers. These insights may help doctors personalize therapies and improve patient care.

Authors

Institutions

Publication Details

Journal
JCO Precision Oncology
Published
2025-08-01
DOI
https://doi.org/10.1200/po-25-00289
Citations
1
Primary Topic
Bladder and Urothelial Cancer Treatments
Type
article
Field-Weighted Citation Impact
2.01
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Comprehensive Comparison of Somatic, Germline, and Immune Cell Profiles in Upper Tract and Bladder Urothelial Carcinoma

Margaret Meagher, Tyler F. Stewart, Jacob Mercer, Arash Rezazadeh Kalebasty et al.
1 citations
JCO Precision Oncology
Bladder and Urothelial Cancer Treatments
2.01
article

Comprehensive Comparison of Somatic, Germline, and Immune Cell Profiles in Upper Tract and Bladder Urothelial Carcinoma

Margaret Meagher, Tyler F. Stewart, Jacob Mercer, Arash Rezazadeh Kalebasty, Nataliya Mar, Shilpa Gupta, Stamatina Fragkogianni, Petros D. Grivas, Binyam Yilma, Amirali Salmasi, Melissa C. Stoppler, Rana R. McKay, Aditya Bagrodia
article en
1 citations

Abstract

By comprehensive molecular characterization of UC, we observed distinct genomic alterations and tumor microenvironment patterns in UTUC and UCB. Further research is warranted to elucidate the clinical implications of these findings. We compared the genetic and immune features of upper tract and bladder cancers. Our study found key differences that could affect treatment decisions, such as specific gene changes and immune markers. These insights may help doctors personalize therapies and improve patient care.

JCO Precision OncologyVol. 9(9)
Cleveland Clinic (US), University of Washington (US), University of California, Irvine (US), UC San Diego Health System (US), Fred Hutch Cancer Center (US), Tempus Labs (United States) (US)
Good health and well-being
Openalex Percentile: Top 13%
Bladder and Urothelial Cancer Treatments
2.01
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Comprehensive Comparison of Somatic, Germline, and Immune Cell Profiles in Upper Tract and Bladder Urothelial Carcinoma — Margaret Meagher, Tyler F. Stewart, et al. · JCO Precision Oncology (2025) | TGRS Research Map | TGRS